There are many difficulties in the development of

2022-08-13
  • Detail

There are many difficulties in the development of the pharmaceutical paperboard packaging market

paperboard packaging is mainly used for the outer packaging box of drugs. At present, the paperboard used in drug packaging boxes mainly includes gray background white board, white background white board with recycled pulp as raw material and white board with fresh wood pulp as raw material. In terms of white cardboard, the market is mainly divided into SBS and FBB. The former uses bleached chemical pulp as raw material and has a two-layer structure, which is characterized by high whiteness, but the stiffness and thickness of the same gram weight paperboard are poor; The latter uses bleached chemical pulp as the surface layer and promising bottom layer of paperboard, and uses mechanical pulp as the raw material to form an intermediate layer to form a three-layer paperboard, which is characterized by high thickness and good hardness under the same gram weight after each spraying, thus bringing good die-cutting effect and crease effect. Due to the difference of paperboard structure, the gram weight of paperboard with the same thickness and stiffness will be different

first, the profit margin of pharmaceutical paperboard packaging is small

at present, the pharmaceutical industry is still in a relatively primitive state in the selection of outer packaging paperboard. When choosing medicine box materials, pharmaceutical enterprises generally choose gray bottom white board paper with recycled pulp as raw material, which is relatively cheap, as the packing material of medicine boxes for the consideration of reducing costs. In particular, over the years, most domestic drugs have been sold to patients through hospitals, and patients have almost no choice over drugs, so it doesn't matter what the drug packaging is. These low-grade gray bottom whiteboards often have fierce competition and limited profit space. As a result, the demand for white cards such as high-end products as products with high profit added value has decreased. But is it really cheap? Let's take a look at an account calculated by an expert specializing in the printing and production of cardboard medicine boxes "For the same packaging box, the average cost difference between high-grade paperboard and cheap paperboard is about 5 cents. Sometimes, due to the different printing quantity, the cost difference is oneortwo cents. However, domestic enterprises are generally unwilling to spend more money, and it is generally believed that if they can save, they will save. In fact, these enterprises have several misconceptions. For example, using high-grade paperboard to replace 300 grams of paperboard with a lower price does not need the same gram, Usually 250 grams is OK, but when domestic enterprises switch to high-grade whiteboard, they still insist on choosing 300 grams of paperboard, resulting in unnecessary waste; Some enterprises believe that only when the price of drugs is high, high-grade packaging cardboard is selected to improve the quality of coal. For low-cost drugs, of course, cheap cardboard is selected; Some enterprises even require that the printed cardboard be covered with film because the low-cost cardboard is not crisp enough, which not only increases the cost of the winners of a total of 6 Awards, such as "outstanding figures/brand enterprises in China's wood plastic industry" elected according to the procedures, but also is very environmentally friendly ". The existence of these enterprises is a common misunderstanding in the whole industry, which cannot be easily changed and will take a long time

second, the demand for drug packaging is strict, which limits the use of cardboard.

with the continuous expansion of the drug market, pharmaceutical enterprises have higher and higher requirements for drug cartons. Drugs are a special commodity, and the consequences of counterfeiting and shoddy are serious. The light will affect the health of consumers, and the heavy will endanger lives. In order to effectively curb counterfeit and shoddy products and maintain the brand of enterprises, pharmaceutical enterprises have high requirements for the anti-counterfeiting of packaging paper; As a kind of commodity, the outer packaging of drugs can reflect the product grade and indirectly reflect the safety and hygiene of products. Therefore, pharmaceutical enterprises pay great attention to the decoration effect of the outer packaging of drugs, and choose cartons with high stiffness and good molding, which can improve the product grade; When consumers buy drugs of the same brand, they usually compare with the packaging of previous batches. If they find that the color of the packaging boxes of new and old batches are different, they will be suspected of counterfeit drugs, so the quality of carton materials is required to be stable; Recently, pharmaceutical enterprises have adopted advanced automatic cartoning machines, which have higher requirements on the weight and straightness of paper. These various requirements for paper will be more stringent, thus limiting the use of some paperboard

III. more than 2000 pharmaceutical enterprises are facing production stoppage, making the paperboard Market worse.

China's pharmaceutical industry GMP certification, from July 1, more than 2000 pharmaceutical manufacturing enterprises that fail to pass the certification will be discontinued, accounting for 40% of the total, and the corresponding dosage of drug boxes will not be available. At the same time, paper packaging has its own shortcomings in pharmaceutical packaging - moisture resistance and protective performance are not ideal. On the other hand, cartons used for sandwich packaging are also facing fierce competition from heat shrinkable plastic packaging. Take 10 boxes or 10 bottles of sandwich packaging for example, the cost of using heat shrinkable plastic packaging is 3 to 7 cents, but carton packaging costs 50 cents to 2 yuan

facing the situation of China's accession to the WTO, foreign drugs will enter the Chinese market on a large scale, tariffs will be lowered, and the barriers of foreign drug price factors will be gradually removed. The market share of foreign medicine has increased, crowding out the domestic pharmaceutical market. The domestic pharmaceutical market will be smaller, and its packaging consumption will also be reduced, while foreign drugs are packaged and imported directly, so there is no corresponding packaging cardboard consumption in China

cardboard has a severe form in the field of pharmaceutical packaging, and its future is full of difficulties

source of information:

Copyright © 2011 JIN SHI